A Confidential Disclosure Agreement (CDA), also known as a Non-Disclosure Agreement (NDA), is a legal contract between at least two parties that describes confidential information that the parties wish to share with each other for specific purposes, but who wish to restrict access by third parties. As a result, a CDA protects non-public information about research and commercial activities from disclosure or use by third parties. CDAs are usually signed when two institutions, companies, individuals or other companies plan to cooperate and need to consult or exchange confidential information. A Confidential Disclosure Agreement (CDA), also known as a Non-Disclosure Agreement (NDA) or Non-Disclosure Agreement, is a legal agreement between at least two parties that describes information that the parties wish to share with each other for specific evaluation purposes, but wish to restrict wider use and dissemination. The parties agree not to disclose non-public information covered by the Agreement. CDAs are typically performed when two parties are considering a relationship or collaboration and must understand the other party`s processes, methods, or technologies solely for the purpose of assessing the potential of a future relationship. You should consider the need for such an agreement whenever you disclose information that is not generally publicly available and you wish to restrict the use or dissemination by the other party. For example, sending a study of your design or protocol to a pharmaceutical company, giving a talk to a pharmaceutical company to discuss your unpublished research, or sharing a potentially patentable idea with an employee outside the university as part of a grant application. A signed version will be faxed to your attention. Once Dalton has received the signed CDA by fax, the agreement is deemed to have been concluded and discussions and/or a review of the technical package may take place in confidence.

Two original documents will be sent to you and a signed original will be returned to Dalton. A Confidential Disclosure Agreement (CDA) is often a precursor to a clinical trial. A company may want to send a protocol to the investigator so that they can decide whether or not to participate in the study. The protocol may contain sensitive information that the company needs to protect. Once a sponsor or contract research organization (CRO) has identified the UTHSCSA as a potential site for a clinical trial, a CDA can be sent to the Principal Investigator (P.I.) for signature. To protect the Health Sciences Centre and the investigator, this agreement must be reviewed and approved by OSP. CDAs are usually simple, but require few changes. Some CDAs may contain requests that the PSO cannot satisfy.

For example, as an educational institution in the state of Texas, the Health Science Center cannot submit to the laws of other states. If the P.I. signs the CDA without verification and signature of the Health Sciences Centre, the IP assumes full responsibility and the Health Sciences Centre will not be able to support it if the conditions of the CDA are violated. Please note that some proponents do not require a CDA. As a general rule, these areas should not be covered by a CDA, as a CDA should normally only allow the use of the information provided for evaluation purposes. The actual implementation of the project should be the subject of a separate contract, by .B. in a clinical trial agreement or in a sponsored research agreement. The adoption of such clauses in a CDA may prevent the researcher or university from freely pursuing its research and results. Perhaps, depending on what the terms of the contract look like. It`s always a good idea to check first, as some agreements strictly limit disclosure to the contact person named in the agreement – usually the lead investigator. CDAs/NDAs are reviewed by several offices at the University of Pittsburgh. The content and purpose of these agreements determine which central body verifies the language and signs it on behalf of the university: as a rule, confidentiality obligations can last from 3 to 5 years, in some cases they can last up to 7 years or more, depending on the agreement.

In any case, it must be carefully checked by the IP. *Subject to the sponsor`s requirements and/or changes to the PSO procedure. Typically, Brown University includes CDAs that are unilateral, i.e. extroverted, so our findings may be shared with third parties for limited and defined purposes prior to publication. Using Brown CDA templates will greatly simplify the process. It can be submitted to the other party within 24 hours. The use of the other party`s submission delays the execution of the document, as negotiations on certain provisions are usually necessary. For your convenience, below is a downloadable Microsoft Word document from Dalton`s standard Mutual Confidentiality Agreement (CDA). Please make changes and email the document with your contact information to Business Development in chemist@dalton.com.

Download the confidentiality agreement in an MS Word document Once the terms of the ADC have been negotiated, OSP sends 2 original CDAs to the I.P. Once you have signed, return both CDAs to OSP for signature. The PSO sends the two originals of the CDA to the proponent. Once OSP receives a fully executed CDA, a copy of your files is sent to the P.I. No. A CDA should not be used to cover the actual conduct of the research, as it would limit the ability of the university and the researcher to publish or otherwise disseminate the results and conclusions drawn from the research. .